← Leaderboards
Peter Celestine Hollenhorst
Indiana University Indianapolis
$2,516,828
Attributed
$3,972,056
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $932.7K · FY2017–22$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,972,056 · 2
By mechanism
R01$3,972,056 · 2
Top collaborators
- Naomi B Haas5 shared
- Roberto Pili5 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Anthony B. Firulli$18,318,152
Others in their field
Other Emerging Leaders on “Signal Pathway”
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Priyamvada Acharya · Duke University$20,941,151
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$9,867,723
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$9,716,114
- James Dale Berry · Brigham And Women'S Hospital$9,298,517
Research focus
Signal PathwayIn VivoMalignant Neoplasm Of ProstateProteinsEzh2 GeneIn VitroPolycombMolecularTumorInhibitor/AntagonistBinding SitesCancer TherapyCell LineCell MotilityBaseAndrogen ReceptorClear Cell Renal Cell CarcinomaAutomobile DrivingChromosomal RearrangementChromatin RemodelingChronicCancer GenomeCancer PatientCancer Etiology
Grant awards (10)
Epigenetic Mechanisms of Drug Resistance in Renal Cell Carcinoma$429,896
R01 · FY2022 · CA
Epigenetic Mechanisms of Drug Resistance in Renal Cell Carcinoma$468,240
R01 · FY2021 · CA
Molecular mechanisms specific to ETS transcription factors that drive oncogenesis$464,469
R01 · FY2021 · CA · contact PI
Epigenetic mechanisms of drug resistance in renal cell carcinoma$406,936
R01 · FY2020 · CA
Molecular mechanisms specific to ETS transcription factors that drive oncogenesis$255,779
R01 · FY2020 · CA · contact PI
Epigenetic mechanisms of drug resistance in renal cell carcinoma$417,407
R01 · FY2019 · CA
Molecular mechanisms specific to ETS transcription factors that drive oncogenesis$349,319
R01 · FY2019 · CA · contact PI
Epigenetic mechanisms of drug resistance in renal cell carcinoma$460,363
R01 · FY2018 · CA
Molecular mechanisms specific to ETS transcription factors that drive oncogenesis$360,124
R01 · FY2018 · CA · contact PI
Molecular mechanisms specific to ETS transcription factors that drive oncogenesis$359,523
R01 · FY2017 · CA · contact PI